| Symbol: |
C16orf7
|
| Description: |
chromosome 16 open reading frame 7 [Source:HGNC Symbol;Acc:13526]
|
| Location: |
Chr16:89773542-89787394[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:156
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| C16orf7 |
NSC 105348 |
0.032 |
Down |
| C16orf7 |
NSC 109834 |
0.01 |
Up |
| C16orf7 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.02 |
Up |
| C16orf7 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.001 |
Up |
| C16orf7 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.007 |
Up |
| C16orf7 |
TZT |
0.013 |
Up |
| C16orf7 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.022 |
Up |
| C16orf7 |
NSC 148201 |
0.036 |
Up |
| C16orf7 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.021 |
Up |
| C16orf7 |
NSC 175296 |
0.045 |
Up |
| C16orf7 |
NSC 17753 |
0.028 |
Up |
| C16orf7 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.006 |
Up |
| C16orf7 |
NSC 191393 |
0.004 |
Down |
| C16orf7 |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.046 |
Up |
| C16orf7 |
NSC 212446 |
0.015 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:null
| SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:31
| Gene |
Gen_transcript |
miRNA |
miR_location |
| C16orf7 |
ENST00000389386 |
hsa-mir-744-5p |
Chr17:11985226-11985247[+] |
|